Allergic Rhinitis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Allergic rhinitis (AR) is a condition marked by symptoms including nasal congestion, clear runny nose, sneezing, postnasal drip, and itching in the nose. The allergic response presents in early and late-phase reactions. Diagnosing allergic rhinitis primarily relies on clinical assessment through a comprehensive history and physical examination, often supplemented by intradermal allergy testing. Treatment options include pharmacological interventions such as antihistamines, intranasal steroids, leukotriene receptor antagonists (LTRAs), and immunotherapy. Intranasal corticosteroids are commonly used alone or combined with oral antihistamines to manage mild, moderate, or severe symptoms. First-generation antihistamines, like diphenhydramine, chlorpheniramine, and hydroxyzine, and second-generation antihistamines, such as fexofenadine, loratadine, desloratadine, and cetirizine, are available choices. While LTRAs like zafirlukast and montelukast may offer relief in allergi...